mouse galectin 3 binding protein  (Cusabio)

Journal: Clinical Proteomics

Article Title: Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison

doi: 10.1186/s12014-019-9227-3

Figure Lengend Snippet: Proteins with > 2 fold abundance alteration with significant abundance change (a) in at least 4/10 EBOV infected NHP when compared to Naive NHP, (b) in at least 2/5 Bp infected

Article Snippet: Western blot assays were performed using a mouse monoclonal antibody for galectin-3 binding protein (LGALS3BP) purchased from Origene (Cat# TA503455).

Techniques: Infection, Binding Assay

Journal: Clinical Proteomics

Article Title: Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison

doi: 10.1186/s12014-019-9227-3

Figure Lengend Snippet: Plasma proteins with significant abundance differences during EBOV versus Bp infection (a) in NHP (b) that are attributed to a temporal differences in the host response

Article Snippet: Western blot assays were performed using a mouse monoclonal antibody for galectin-3 binding protein (LGALS3BP) purchased from Origene (Cat# TA503455).

Techniques: Infection, Binding Assay

Journal: Clinical Proteomics

Article Title: Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison

doi: 10.1186/s12014-019-9227-3

Figure Lengend Snippet: Leucine-rich alpha-2 glycoprotein 1 (LRG1) and galectin-3 binding protein (G3BP) increase during EBOV infection in rhesus macaques. Neither protein was quantitated in naïve NHP plasma a Leucine-rich alpha-2 glycoprotein (LRG1) abundance levels increased to > 3 fold on Day 5 PI during EBOV infection whereas, Bp -infected NHPs exhibited a very slight increase. LRG1 levels were significantly higher in EBOV-infected animals on Days 5 and 6/7 PI (indicated with * symbol, based on 2-way ANOVA analysis). b G3BP abundance increased in EBOV-infected NHPs by > 2.5 fold on Day 6 PI, and was only quantitated in 1/5 Bp -infected animals. c Representative data from EBOV-infected NHP 1000 depicting Western blot confirmation of the FASP/TMT increased abundance of G3BP observed during EBOV infection. Equal volumes of plasma (5 μl) were loaded for each sample. No bands are visible in plasma from Bp -infected NHP JD27, confirming baseline levels and no increase during Bp infection. d FASP/TMT quantitation for G3BP for NHP 1000 (EBOV-infected: filled circle) and NHP JD27 ( Bp -infected: filled square)

Article Snippet: Western blot assays were performed using a mouse monoclonal antibody for galectin-3 binding protein (LGALS3BP) purchased from Origene (Cat# TA503455).

Techniques: Binding Assay, Infection, Western Blot, Quantitation Assay